In this issue:
RANZCP guidance for psychedelic-assisted therapy
Analysis of substances prevalent in poisoning- and non-poisoning-related suicides in Australia
Repeated IV esketamine for adolescents with MDD and suicidal ideation
Pregnancy, delivery, and neonatal outcomes associated with maternal OCD
Investigational therapy for amygdala-driven mental health conditions
Association between depression with incident dementia
Access to MDMA and psilocybin for therapeutic purposes
Mental health case conferencing items
Opioid dependence treatment program: Access changes
Critical boost for the psychiatry workforce
No association between illicit drug use following stimulant use for ADHD
Next-Generation EarliPoint evaluation for ASD
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)